Posts Tagged ‘patients’

  According to an article in Clinical Leader that featured Bayer Healthcare’s VP Global Strategy & Development Advisor, by evaluating certain criteria against patient populations, electronic health record (EHR) systems can help sponsors determine trial feasibility and shape better study protocols. This can reduce the number of amendments, which can cost anywhere from $300,000 to […]

  Recruiting subjects for clinical trials has been a longstanding challenge for pharmaceutical and research organizations. According to Dr. Steven Alberts, Chair of Medical Oncology with the Mayo Clinic, only 5% of cancer patients ever enroll in a trial. On top of that, only a fraction of all trials ever finish enrolling enough patients on […]

  Following an 18-month-long investigation by the United States Senate Committee on Finance, Gilead’s pricing and marketing strategy for its hepatitis drugs, Sovaldi and Harvoni, was deemed one that chooses profit over patient access. In order to appropriately shape policy related to these findings, the Committee has written a letter to the healthcare and patient […]

It’s no secret that patients struggle with taking their medication. Whether they forget or purposely avoid taking it, a patient’s outcome could be affected. If a patient is in a clinical trial and isn’t following protocol by taking their medication as instructed, it ruins the legitimacy of the trial’s data and ultimately puts other lives […]

  In today’s digital age, consumers have evolved to become far more independent and self-sufficient. They now expect access to information, services, and products to be quick, easy, useful, engaging, and even entertaining. Businesses that are not yet meeting these new expectations are falling behind the curve. 

  Clinical trials face long delays and, in some cases, are even cancelled because too few subjects are enrolled. Sponsors and CROs have different recruitment strategies, from advertising through mainstream media (although this practice is not as widespread you’d think) to the use of mobile and digital applications. But, one of the most effective ways […]

  Several months ago I posted Why Don’t I See Ads For Clinical Trials?, a piece in which I questioned just that. In a society where healthcare is always front and center, how is it that most of us are still unaware of our options when it comes to participating in clinical research? 

  This is a question most of us hear when picking up prescriptions at a pharmacy. But, have you ever questioned the information the pharmacist gives you? Were his or her answers accurate? Did that information take your personal situation, such as your medical history, into consideration? What’s the source of the information they provide, […]

  This struck me as interesting: The Boston Globe wrote an article on how doctors at Brigham and Women’s Hospital (BWH) are encouraged to share medical errors. In fact, they are asked to do so, knowing that the information will be published in a case study-like format for the public to see. The objective is […]

  Check this out. Roche just developed a mobile app, which is currently being evaluated in a Phase I trial, that can help assess the severity of one’s Parkinson’s disease (PD). Here’s how it works: Patients are provided with pre-configured smartphones and, over time, are guided through a series of tests to collect data points. […]

  Digital transformation (DT), the concept of leveraging digital technologies to engage with constituents (e.g., customers, patients, employees, or partners) is vital in today’s world. The audience you’re targeting expects communication to be easy and information to be readily available at any time. If they can’t get what they want from you, they’ll go somewhere […]

  There’s a lot of talk these days about digital transformation: changing the way companies interact with their constituents. In general, the movement has not focused on specific groups of people…until now.